The Trump administration’s moves on marijuana and psychedelics signal the start of a new …
✦ New CED Clinical Relevance #55 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyResearchMental Health Clinical Summary I don’t have access to the full article content needed to write an…
White House drug czar says cannabis is “still illegal” after rescheduling (Newsletter: May 11, 2026)
✦ New CED Clinical Relevance #55 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyResearchAgingMental Health Why This Matters Clinicians need to understand that despite the DEA’s…
White House National Drug Control Strategy Presents Conflicting Stances on Medical …
✦ New CED Clinical Relevance #65 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchMental HealthSafety Why This Matters Clinicians need clarity on federal cannabis policy to confidently…
US Federal Policy on Medical Cannabis Rescheduling: A Step Forward with Remaining …
✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. PolicyResearchSafety Why This Matters Federal rescheduling of cannabis could legitimize prescribing practices that…
White House Drug Czar Clarifies That Marijuana Is ‘Still Illegal’ Following Trump …
✦ New CED Clinical Relevance #55 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyHempTHC Why This Matters Clinicians need to understand that federal recriminalization of hemp-derived THC products…
Congress considers veterans’ medical cannabis amendment (Newsletter: May 8, 2026)
✦ New CED Clinical Relevance #65 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyMental HealthResearchSafety Why This Matters If Congress passes a veterans’ medical cannabis amendment, it…
DEA Reiterates Stance That Lab-Derived Cannabinoids Are Not Compliant With the Farm Bill
✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. PolicyResearchHempIndustry Why This Matters Clinicians need to understand that synthetic cannabinoids derived from…
DOJ Reschedules Medical Marijuana: What It Means for Insurance Coverage
The DOJ's rescheduling of medical marijuana has significant medical marijuana insurance coverage implications. This change may increase insurance reimbursement options and reduce patient costs. Clinicians can now better guide patients on accessing…
The Biggest Things About Schedule III You Haven’t Thought Of | Cannabis Business Times
✦ New CED Clinical Relevance #65 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchIndustry Clinical Summary # Clinical Summary The potential rescheduling of cannabis from Schedule I to…
Federal marijuana reclassification could reshape medical research and cannabis industry
✦ New CED Clinical Relevance #65 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchIndustryAging Clinical Summary The potential federal reclassification of marijuana from Schedule I to a…